News Articles on Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Launches Hemophilia Self-Infusion Training Program

WAYNE, N.J., July 9 /PRNewswire/ -- Today, Bayer HealthCare Pharmaceuticals launched the BayCuff(TM) self-infusion training program, an educational
http://www.bioportfolio.com/news/Bayer_HealthCare_Launches_Hemophilia.html - Thursday July 9 2009

Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer

WAYNE, N.J., EMERYVILLE, Calif. and MELVILLE, N.Y., May 28 /PRNewswire-FirstCall/ -- Bayer HealthCare LLC., Onyx Pharmaceuticals, Inc. (Nasdaq: ONX
http://www.bioportfolio.com/news/Phase_3_Trial_Initiated_to_Evaluate_Combination.html - Thursday May 28 2009

Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology

WAYNE, N.J., May 22 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. today announced that new data on Bayer's novel anti-cance
http://www.bioportfolio.com/news/Bayer_to_Present_Data_on_Development_Compound_BAY.html - Friday May 22 2009

New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes

SEATTLE, April 29 /PRNewswire/ -- New analyses of data from the 16-Year Long-term Follow-up study with Betaseron(R) (interferon beta-1b), sponsored
http://www.bioportfolio.com/news/New_Analyses_from_16-Year_Follow-up_Trial_with.html - Wednesday April 29 2009

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

WAYNE, N.J., Dec. 5 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that data on Campath(R) (alemtuzumab) and Leukine(R) (sa
http://www.bioportfolio.com/news/Bayer_Announces_Upcoming_Presentations_of.html - Friday December 5 2008

Betaseron(R) to Offer the Thinnest Needle in Multiple Sclerosis

WAYNE, N.J., Sept. 15 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that Betaseron(R)* (interferon beta-1b), its treatm
http://www.bioportfolio.com/news/Betaseron%28R%29_to_Offer_the_Thinnest_Needle_in.html - Monday September 15 2008

Silver Medalist Jennie Finch & Relationship Expert Stacy Kaiser Help 'Wired' Couples Unplug

WAYNE, N.J., Aug. 28 /PRNewswire/ -- Many couples live in a "wired" world, juggling lengthy to-do lists, jam-packed schedules, and th
http://www.bioportfolio.com/news/Silver_Medalist_Jennie_Finch_%26amp%3B_Relationship.html - Thursday August 28 2008

Gold Medalist Jennie Finch & Relationship Expert Stacy Kaiser Help 'Wired' Couples Unplug

WAYNE, N.J., July 30 /PRNewswire/ -- Many couples live in a "wired" world, juggling lengthy to-do lists, jam-packed schedules, and th
http://www.bioportfolio.com/news/Gold_Medalist_Jennie_Finch_%26amp%3B_Relationship.html - Wednesday July 30 2008

FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions

WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food a
http://www.bioportfolio.com/news/FDA_Approves_EOVIST%28R%29_to_Detect_and_Characterize.html - Tuesday July 8 2008

Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients

WAYNE, N.J., June 5 /PRNewswire/ -- Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of patients trea
http://www.bioportfolio.com/news/Study_Supports_Possible_Use_of_Leukine%28R%29_as_a.html - Thursday June 5 2008